Akers Says It's Halfway Through Plan To Develop COVID-19 Vaccine Candidate [Yahoo! Finance News]
Rockwell Medical, Inc. (RMTI)
Last rockwell medical, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.rockwellmed.com
Company Research
Source: Yahoo! Finance News
Akers Biosciences IncAKERsaidThe New Jersey-based company said that it, along with developmental partner Premas Biotech, has successfully completed the second milestone of successful expression of the three coronavirus antigens — spike, envelop and membrane —selected for their vaccine candidate.Benzinga is covering every angle of how the coronavirus affects the financial world.For daily updates,sign up for our coronavirus newsletter"The antigens have been expressed using the D-CryptTM platform at Premas Biotech, which utilizes its vectors and S cerevisiae strain," according to Akers.Premas will now move ahead with purification and post-expression processing that will lead to a scaling up of the antigen, according to a press release.The company is now halfway through a four-milestone plan that it believes will lead to the commencement of clinical trials, Akers Executive Chairman Christopher Schreiber said in a statement.Akers shares were advancing 6.14% to $6.05 at the time of publicat
Show less
Read more
Impact Snapshot
Event Time:
RMTI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMTI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMTI alerts
High impacting Rockwell Medical, Inc. news events
Weekly update
A roundup of the hottest topics
RMTI
News
- Rockwell Medical to Release Fourth Quarter and Full-Year 2025 Results on Thursday, March 26, 2026 [Yahoo! Finance]Yahoo! Finance
- Rockwell Medical to Release Fourth Quarter and Full-Year 2025 Results on Thursday, March 26, 2026Business Wire
- Rockwell Medical Named 'Great Place to Work' for Fourth Year in a RowBusiness Wire
- Is Rockwell Medical (RMTI) Stock Undervalued Right Now? [Yahoo! Finance]Yahoo! Finance
- Rockwell Medical (NASDAQ:RMTI) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $2.50 price target on the stock.MarketBeat
RMTI
Earnings
- 11/12/25 - Beat
RMTI
Analyst Actions
- 1/26/26 - HC Wainwright
RMTI
Sec Filings
- 1/20/26 - Form 8-K
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- RMTI's page on the SEC website